The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: Contribution of universal HBV vaccination in Italy

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Coppola, Nicola ^a   Corvino, Anna Rita ^a   De Pascalis, Stefania ^a   Signoriello, Giuseppe ^a   Di Fiore, Eliana ^a   Nienhaus, Albert ^b   Sagnelli, Evangelista ^a   Lamberti, Monica ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Anti HBs titer; HBV infection; HBV vaccination; Healthcare students

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; BIOLOGICAL MARKER; HEPATITIS B ANTIBODY; RECOMBINANT VACCINE;

ADULT; AGE DISTRIBUTION; ANTIBODY TITER; ARTICLE; DEMOGRAPHY; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; ITALY; MALE; MEDICAL STUDENT; SEX DIFFERENCE; SEX RATIO; TREATMENT OUTCOME; VACCINATION; BLOOD; CHILD; EVALUATION STUDY; IMMUNOLOGY; NEWBORN; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADULT; BIOMARKERS; CHILD; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INFANT, NEWBORN; ITALY; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; VACCINES, SYNTHETIC;

EID: 84925640036     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0874-3     Document Type: Article

References (35)

1. Kane MA. Global status of hepatitis B immunization. Lancet. 1996;348:696.
2. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733-45.
3. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol. 2005;34 Suppl 1:S1-3.
4. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;14(373):582-92.
5. Sagnelli E, Sagnelli C, Pisaturo M, Macera M, Coppola N. Epidemiology acute and chronic hepatitis B and delta over the last 5 decades in Italy. World J Gastroenterol. 2014;20:7635-43.
6. Sagnelli E, Stroffolini T, Mele A, Imparato M, Almasio PL, Italian Hospital Collaborating group. Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection. Clin Infect Dis. 2008;46:110-3.
7. Piccinino F, Manzillo G, Sagnelli E, Balestrieri G, Maio G. Familial clustering of hepatitis B antigen and liver diseases in families with a high incidence of viral hepatitis. Infection. 1975;3:99-104.
8. Crovari P. Epidemiology of viral hepatitis B in Italy. Vaccine. 1995;13(Suppl1):S26-30.
9. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26:6266-73.
10. Piazza M, Da Villa G, Picciotto L, Abrescia N, Guadagnino V, Memoli AM, et al. Mass vaccination against hepatitis B in infants in Italy. Lancet. 1988;332:1132.
11. Zanetti AR, Tanzi E, Romanò L, Grappasonni I. Vaccination against hepatitis B: the Italian strategy. Vaccine. 1993;11:521-4.
12. Romanò L, Paladini S, Tagliacarne C, Zappa A, Zanetti AR. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination. Vaccine. 2009;26:3439-42.
13. Zanetti AR, Mariano A, Romanò L, D'amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005;366:1379-84.
14. Boxall EH, Sira JA, El-Shuhkri N, Kelly DA. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis. 2004;190:1264-9.
15. Faustini A, Franco E, Sangalli M, Spadea T, Calabrese RM, Cauletti M, et al. Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy. Vaccine. 2001;19:2812-8.
16. Campagna M, Siddu A, Meloni A, Murru C, Masia G, Coppola RC. Epidemiological impact of mandatory vaccination against hepatitis B in italian young adults. Hepat Mon. 2011;11:750-2.
17. Stroffolini T, Guadagnino V, Caroleo B, De Sarro G, Focà A, Liberto MC, et al. Long-term immunogenicity oh hepatitis B vaccination in children and adolescents in a southern Italian town. Infection. 2012;40:299-302.
18. Gabbuti A, Romanò L, Blanc P, Meacci F, Amendola A, Mele A, et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine. 2007;25:3129-32.
19. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev. 1988;10:212-41.
20. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-years follow up. Ann Intern Med. 2005;142:333-41.
21. Spada E, Romanò L, Tosti ME, Zuccaro O, Paladini S, Chironna M, et al. Hepatitis B immunity in teenager. vaccinated as infants: an Italian 17-year follow-up study. Clin Microbiol Infect. 2014;20:O680-6.
22. Teoharov P, Kevorkyan A, Petrova N, Baltadzhiev I, Van Damme P. Immune memory and immune response in children from Bulgaria 5-15 years after primary hepatitis B vaccination. Pediatr Infect Dis J. 2013;32:51-3.
23. Zhu CL, Liu P, Chen T, Ni Z, Lu LL, Huang F, et al. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination. Vaccine. 2011;29:7835-41.
24. Zanetti AR, Romanò L, Giambi C, Pavan A, Carnelli V, Baitelli G, et al. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Lancet Infect Dis. 2010;10:755-61.
25. Gara N, Abdalla A, Rivera E, Zhao X, Werner JM, Liang TJ, et al. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults. Clin Infect Dis. 2015;60:505-13.
26. Siegrist CA. Vaccination in the neonatal period and early infancy. Int Rev Immunol. 2000;19:195-219.
27. Siegrist CA, Cordova M, Brandt C, Barrios C, Berney M, Tougne C, et al. Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine. 1998;16:1409-14.
28. Buffington J, Mast E. Viral hepatitis. In: Wallace RB, editor. Wallace/MaxcyRosenau-last public health and preventive medicine. 15th ed. New York: Mc Graw Hill; 2007. p. 211-28.
29. Dlgs 9/4/2008, n. 81. Testo unico sulla salute e sicurezza al lavoro. G.U. n.101 30/04/2008 -Supplemento Ordinario n.108: http://www.gazzettaufficiale.it/eli/id/2008/04/30/008G0104/sg
30. Askarian M, Yadollahi M, Kuochak F, Danaei M, Vakili V, Momeni M. Precautions for health care workers to avoid hepatitis B and C virus infection. Int J Occup Environ Med. 2011;2:191-8.
31. Elseviers MM, Arias-Guillén M, Gorke A, Arens HJ. Sharps injuries amongst healthcare workers: review of incidence, transmissions and costs. J Ren Care. 2014;40:150-6.
32. Centers for Disease Control and Prevention (CDC). Immunization of healthcare workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR. 1997;46:1-42.
33. European Consensus Group on Hepatitis B Immunity. Consensus statement. Are booster immunizations needed for lifelong hepatitis B immunity? Lancet. 2000;5(355):561-5.
34. OSHA. Occupational Safety and Health Administration. Enforcement procedures for the occupational exposure to bloodborne pathogens. Directive N° CPL 2-2.69; Standard N° 1910.1030. Washington DS, USA: Office of Health Compliance Assistence; 2001.
35. Alessio L, Porru S, Longo F. Linee Guida SIMLII per la sorveglianza sanitaria dei lavoratori della sanità esposti a rischio biologico. Pavia: PI-ME Ed; 2005.